AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Onconetix, Inc. Director's Dealing 2024

Sep 26, 2024

35411_dirs_2024-09-26_e9a04549-ddb3-4ca6-9a01-da04189fdc69.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconetix, Inc. (ONCO)
CIK: 0001782107
Period of Report: 2024-09-24

Reporting Person: Schiess Ralph (Interim CEO & CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-24	Common Stock	A	489160	—	Acquired	495903.	Direct

Footnotes

F1: Represents shares of common stock of the Issuer issued to the Reporting Person upon automatic conversion of Series B preferred stock ("Preferred Shares") of the Issuer, in accordance with the Certificate of Designation for the Preferred Shares.